Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells
Chih-Ta Chen, Li-Zhu Liao, Ching‐Hui Lu, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 3, pp. 497-513
Open Access | Times Cited: 19

Showing 19 citing articles:

Eph receptors and ephrins in cancer progression
Elena B. Pasquale
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 5-27
Open Access | Times Cited: 55
Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review
Josef Yayan, Karl-Josef Franke, Melanie Berger, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 29
A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis
Pey Yee Lee, Yeelon Yeoh, Teck Yew Low
FEBS Journal (2022) Vol. 290, Iss. 11, pp. 2845-2864
Closed Access | Times Cited: 52
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
Rafaela Nasser Veiga, Alexandre Luiz Korte de Azevedo, Jaqueline Carvalho de Oliveira, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 479-493
Closed Access | Times Cited: 7
Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
Li-Zhu Liao, Chih-Ta Chen, Nien‐Chen Li, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 224-224
Open Access | Times Cited: 35
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
Mario Cioce, Vito Michele Fazio
Cancers (2021) Vol. 13, Iss. 4, pp. 700-700
Open Access | Times Cited: 22
S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
Wei‐Chih Liao, Chih-Ta Chen, You-Shu Tsai, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers
Morteza Abyadeh, Anna Meyfour, Vivek Gupta, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8532-8532
Open Access | Times Cited: 19
Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling
Chih-Ta Chen, Peihua Wu, Chia-Chi Hu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11661-11661
Open Access | Times Cited: 16
Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice
Ankita Punetha, Deepak Kotiya
Proteomes (2023) Vol. 11, Iss. 1, pp. 2-2
Open Access | Times Cited: 7
p21 activated kinase-1 and tamoxifen – A deadly nexus impacting breast cancer outcomes
Swetha Rajendran, Srikanth Swamy Swaroop, Joydeep Roy, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188668-188668
Closed Access | Times Cited: 13
Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms
Mandeep Dahiya, Harish Dureja
Journal of Chemotherapy (2021) Vol. 34, Iss. 5, pp. 286-301
Closed Access | Times Cited: 11
Proteolytic cleavage of membrane proteins by membrane type‐1 MMP regulates cancer malignant progression
Kazuki Ikeda, Ryo Kaneko, Eiki Tsukamoto, et al.
Cancer Science (2022) Vol. 114, Iss. 2, pp. 348-356
Open Access | Times Cited: 6
Adhesion, Metastasis, and Inhibitor for Cancer Cells
Josef Yayan, Karl-Josef Franke, Melanie Berger, et al.
(2023)
Open Access | Times Cited: 2
Expression of miR-210-3p in the aqueous humor of patients with age-related cataracts and its effect on human lens epithelial cell injury induced by hydrogen peroxide
Xu Chen, Jianping Xu, Wenlong Zhang, et al.
Arquivos Brasileiros de Oftalmologia (2023) Vol. 87, Iss. 5
Open Access | Times Cited: 1
The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells
Evelyn D. Harris, Jessica C. Sharpe, Timothy G. Strozen, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1201-1201
Open Access
Advances in hepatocellular carcinoma drug resistance models
Yien Xiang, Junhua Wu, Hanjiao Qin
Frontiers in Medicine (2024) Vol. 11
Open Access
A dataset resource for clinically associated phosphosites in hepatocellular carcinoma
Qian Meng, Yuqiu Wang, Dayun Lu, et al.
PROTEOMICS (2022) Vol. 23, Iss. 3-4
Closed Access | Times Cited: 2
miR-21 Targets ASPP2 to Inhibit Apoptosis via CHOP-Mediated Signaling in Helicobacter pylori-Infected Gastric Cancer Cells
Bo‐Shih Huang, Chih-Ta Chen, Chao-Chi Yeh, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-20
Open Access
Page 1

Scroll to top